Loading…

PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor

Saved in:

Bibliographic Details
Published in:	Value in health 2020-12, Vol.23, p.S479-S480
Main Authors:	Casasnovas, R.O., Daniele, P., Tremblay, G., Maerevoet, M., Zijlstra, J., Follows, G., Vermaat, J.S.P., Kalakonda, N., Goy, A.H., Choquet, S., Van Den Neste, E., Hill, B.T., Thieblemont, C., Cavallo, F., de la Cruz, F., Kuruvilla, J., Hamad, N., Bouabdallah, R., Jäger, U., Caimi, P., Gurion, R., Warzocha, K., Bakhshi, S., Sancho, J.M., Schuster, M., Egyed, M., Offner, F., Vasilakopoulos, T., Samal, P., Nagy, A., Ku, M., Canales Albendea, M.Á.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!